Adjuvant chemotherapy in muscle-invasive bladder carcinoma: A pooled analysis from phase III studies

Cancer

Volumn 106, Issue 4, 2006, Pages 783-788

  Ruggeri, Enzo Maria ^a   Giannarelli, Diana ^a   Bria, Emilio ^a   Carlini, Paolo ^a   Felici, Alessandra ^a   Nelli, Fabrizio ^b   Gallucci, Michele ^a   Cognetti, Francesco ^a   Pollera, Camillo Francesco ^b  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^b BELCOLLE HOSPITAL   (Italy)

Author keywords

Adjuvant chemotherapy; Bladder carcinoma; Metaanalysis; Survival

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; BLADDER CARCINOMA; CANCER ADJUVANT THERAPY; CANCER RECURRENCE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CYSTECTOMY; DISEASE FREE SURVIVAL; ERADICATION THERAPY; HUMAN; INVASIVE CARCINOMA; MICROMETASTASIS; OVERALL SURVIVAL; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; TREATMENT INDICATION;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; CLINICAL TRIALS, PHASE III; CYSTECTOMY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PROGNOSIS; RISK FACTORS; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS;

EID: 32544457106     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.21676     Document Type: Article

References (29)

1. Parkin DM, Pisani P, Ferlay J. Global cancer statistics. CA Cancer J Clin. 1999;49:33-64.
2. Vaidya A, Soloway MS, Hawke C, et al. De novo muscle invasive bladder cancer: is there a change in trend? J Urol. 2001;165:47-50.
3. Stein JP, Grossfeld GD, Freeman JA, et al. Orthotopic lower urinary tract reconstruction in women using the Kock ileal neobladder: updated experience in 34 patients. J Urol. 1997;158:400-405.
4. Elmajian DA, Stein JP, Esrig D, et al. The Kock ileal neobladder: updated experience in 295 male patients. J Urol. 1996;156:920-925.
5. Stein JP, Lieskovsky G, Cote R, et al. Radical cystectomy in the treatment of invasive bladder cancer: long term results in 1054 patients. J Clin Oncol. 2001;19:666-675.
6. Ghoneim MA, el-Mekresh MM, el-Baz MA, et al. Radical cystectomy for carcinoma of the bladder: critical evaluation of the results in 1026 cases. J Urol. 1997;158:393-399.
7. Madersbacher S, Hochreiter W, Burkhard F, et al. Radical cystectomy for bladder cancer today-a homogeneous series without neoadjuvant chemotherapy. J Clin Oncol. 2003;21:690-696.
8. Vale C, for the Advanced Bladder Cancer (ABC) Meta-analysis Collaboration. Neoadjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis. Lancet. 2003;361:1927-1934.
9. Winquist E, Kirchner TS, Segal R, et al. Neoadjuvant chemotherapy for transitional cell carcinoma of the bladder. A systematic review and meta-analysis. J Urol. 2004;171:561-569.
10. Logothethis CJ, Johnson DE, Chong C, et al. Adjuvant cyclophosphamide, doxorubicin and cisplatin chemotherapy for bladder cancer. An update. J Clin Oncol. 1988;6:1590-1596.
11. Skinner DG, Daniels JR, Russell CA, et al. The role of adjuvant chemotherapy following cystectomy for invasive bladder cancer: a prospective comparative trial. J Urol. 1991;145:459-467.
12. Stockle M, Meyenburg W, Wellek S, et al. Advanced bladder cancer (stages pT3b, pT4a, pN1 and pN2): improved survival after radical cystectomy and 3 adjuvant cycles of chemotherapy. Results of a controlled prospective study. J Urol. 1992;148:302-307.
13. Studer UE, Bacchi M, Biedermann C, et al. Adjuvant cisplatin chemotherapy following cystectomy for bladder cancer: a prospective randomized trial. J Urol. 1994;152:81-84.
14. Freiha F, Reese J, Torti FM. A randomised trial of radical cystectomy versus radical cystectomy plus cisplatin, vinblastine and methotrexate chemotherapy for muscle invasive bladder cancer. J Urol. 1996;155:495-500.
15. Bono AV, Benvenuti C, Reali L, et al. Adjuvant chemotherapy in advanced bladder cancer. Prog Clin Biol Res. 1989;303:533-540.
16. Sylvester R, Sternberg C. The role of adjuvant combination chemotherapy after cystectomy in locally advanced bladder cancer: what we do not know and why. Ann Oncol. 2000;11:851-856.
17. National Cancer Institute. Levels of evidence for adult cancer treatment studies, health professional version (date last modified: 6/6/2003). Available at URL: http://www.cancer. gov [accessed December 31, 2004].
18. Pignon JP, Hill C. Meta-analyses of randomized clinical trials in oncology. Lancet Oncol. 2001;2:475-482.
19. Bria E, Giannarelli D, Felici A, et al. Taxanes with anthracyclines as first-line chemotherapy for metastatic breast carcinoma. Cancer. 2005;103:672-679; Jan 6 [Epub ahead of print].
20. Parmar MKB, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med. 1998;17:2815-2834.
21. Douglas Case L, Kimmick G, Paskett ED, et al. Interpreting measures of treatment effect in cancer clinical trials. Oncologist. 2002;7:181-187.
22. Parmar MKB, Machin D. Survival analysis: a practical approach. Chichester, UK: John Wiley & Sons, 1995.
23. Millikan R, Dinney C, Swanson D, et al. Integrated therapy for locally advanced bladder cancer: final report of a randomised trial of cystectomy plus adjuvant M-VAC versus cystectomy with both preoperative and postoperative M-VAC. J Clin Oncol. 2001;19:4005-4013.
24. Stockle M, Meyenburg W, Wellek S, et al. Adjuvant polychemotherapy of non organ-confined bladder cancer after radical cystectomy revisited: long-term results of a controlled prospective study and further clinical experience. J Urol. 1995;153:47-52.
25. Stockle M, Wellek A, Meyenburg W, et al. Radical cystectomy with or without adjuvant polychemotherapy for non organ-confined transitional cell carcinoma of the urinary bladder: prognostic impact of lymphnode involvement. Urology. 1996;48:868-875.
26. Bono AV, Benvenuti C, Gibba A, et al. Adjuvant chemotherapy in locally advanced bladder cancer. Final analysis of a controlled multicentre study. Acta Urol Ital. 1997;11:5-8.
27. Logothetis CJ, Dexeus FH, Finn L, et al. A prospective randomized trial comparing MVAC and CISCA chemotherapy for patients with metastatic urothelial tumors. J Clin Oncol. 1990;8:1050-1055.
28. Loehrer PJ, Einhorn LH, Elson PJ, et al. A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study. J Clin Oncol. 1992;10:1066-1073.
29. Piedbois P. Meta-analyses based on abstracted data: a step in the right direction, but only a first step. J Clin Oncol. 2004;9:3839-3841.